副鼻腔炎(Sinusitis)：治療薬開発パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Sinusitis Overview 6
Therapeutics Development 7
Pipeline Products for Sinusitis – Overview 7
Pipeline Products for Sinusitis – Comparative Analysis 8
Sinusitis – Therapeutics under Development by Companies 9
Sinusitis – Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Sinusitis – Products under Development by Companies 13
Sinusitis – Companies Involved in Therapeutics Development 14
Amgen Inc. 14
Clarassance, Inc. 15
Cubist Pharmaceuticals, Inc. 16
F. Hoffmann-La Roche Ltd. 17
Knopp Biosciences LLC 18
Myelo Therapeutics GmbH 19
Regeneron Pharmaceuticals, Inc. 20
Zambon Company S.p.A. 21
Sinusitis – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Target 23
Assessment by Mechanism of Action 25
Assessment by Route of Administration 27
Assessment by Molecule Type 29
Drug Profiles 31
AMG-282 – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
CG-201 – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
dexpramipexole dihydrochloride – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
dupilumab – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
fluticasone propionate – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Myelo-001 – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
omalizumab – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
solithromycin – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
ZP-031 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Sinusitis – Recent Pipeline Updates 45
Sinusitis – Dormant Projects 61
Sinusitis – Product Development Milestones 62
Featured News & Press Releases 62
Sep 30, 2014: Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 62
Appendix 63
Methodology 63
Coverage 63
Secondary Research 63
Primary Research 63
Expert Panel Validation 63
Contact Us 63
Disclaimer 64